This topic contains a solution. Click here to go to the answer

Author Question: Why are inhaled steroids used to treat asthma and chronic obstructive pulmonary disease (COPD)? ... (Read 164 times)

V@ndy87

  • Hero Member
  • *****
  • Posts: 571
Why are inhaled steroids used to treat asthma and chronic obstructive pulmonary disease (COPD)?
 
  A) They act locally to decrease release of inflammatory mediators.
  B) They act locally to improve mobilization of edema.
  C) They act locally to increase histamine release.
  D) They act locally to decrease histamine release.

Question 2

What drug might the nurse administer for both analgesic and antitussive effects?
 
  A) Codeine
  B) Aspirin
  C) Ibuprofen
  D) Acetaminophen



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

allisonblackmore

  • Sr. Member
  • ****
  • Posts: 330
Answer to Question 1

A
Feedback:
When administered into the lungs by inhalation, steroids decrease the effectiveness of the inflammatory cells. This has two effects, which are decreased swelling associated with inflammation and promotion of beta-adrenergic receptor activity, which may promote smooth muscle relaxation and inhibit bronchoconstriction . Options B, C, and D are incorrect.

Answer to Question 2

A
Feedback:
Codeine is a narcotic drug used for its analgesic and antitussive effects. Aspirin, ibuprofen, and acetaminophen do not have antitussive effects.





 

Did you know?

Long-term mental and physical effects from substance abuse include: paranoia, psychosis, immune deficiencies, and organ damage.

Did you know?

The heart is located in the center of the chest, with part of it tipped slightly so that it taps against the left side of the chest.

Did you know?

The term pharmacology is derived from the Greek words pharmakon("claim, medicine, poison, or remedy") and logos ("study").

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library